Table 3.
Predictors/covariates | Total drug spending | Proportion drug spending | ||
---|---|---|---|---|
|
|
|||
Model 1 OR (SE) | Model 2 OR (SE) | Model 1 OR (SE) | Model 2 OR (SE) | |
Week | 0.52 (0.02)*** | 0.52 (0.02)*** | 0.52 (0.02)*** | 0.52 (0.02)*** |
Week2 | 1.04 (0.004)*** | 1.04 (0.004)*** | 1.04 (0.004)*** | 1.04 (0.004)*** |
Years of education | 1.07 (0.05) | 1.05 (0.05) | 1.10 (0.05)* | 1.09 (0.05)* |
Major depression (lifetime) | 0.80 (0.16) | 0.80 (0.16) | 0.73 (0.15) | 0.73 (0.15) |
Pre-treatment prescription opioid use | 1.03 (0.03) | 1.03 (0.03) | 1.04 (0.03) | 1.04 (0.03) |
Heroin use | 2.00 (0.44)*** | 2.06 (0.45)*** | 1.88 (0.41)** | 1.92 (0.42)** |
Non-oral use of prescription opioids | 0.66 (0.19) | 0.63 (0.18) | 0.68 (0.20) | 0.67 (0.20) |
Drug spending (total or proportion) | 1.27 (0.08)*** | 1.30 (0.09)*** | 1.31 (0.08)*** | 1.31 (0.08)*** |
Doctor obtaining frequency score | 0.94 (0.07) | 0.92 (0.06) | ||
Dealer/patient obtaining score | 0.90 (0.08) | 0.94 (0.08) |
p < .05,
p < .01,
p < .001.